Advanced MRIdian Linac Guided Radiation Therapy Program Marks 5th Year at Baptist Health Miami Cancer Institute
Recently celebrating its five-year anniversary treating with the MRIdian Linac, the Institute has become widely recognized as an international leader in MR-guided radiation therapy, known for successfully treating the most challenging tumors including those that typically do not respond to standard doses of radiation.
“Treatment was exceptionally well-tolerated, despite the exceptionally high dose, which was made possible by the advanced features of MRIdian. It was also encouraging that patients themselves reported that the high-dose radiation therapy did not negatively impact their quality of life.”
"A significant number of our patients have surpassed the expected survival for this deadly disease, with many alive several years after their initial diagnosis,” said Michael Chuong, M.D., director of MRI-Guided Radiation Therapy at the Institute and a radiation oncologist specializing in gastrointestinal cancers.
Pioneer in MRIdian Linac Guided Radiation Therapy
In April 2018, Baptist Health Miami Cancer Institute became one of the first centers in the world to treat patients with the ViewRay™ MRIdian Linac, the first FDA-cleared MR (magnetic resonance)-guided radiation therapy system.
Cutting Edge Treatment In One Place
Miami Cancer Institute offers one of the world’s most comprehensive and advanced radiation oncology programs, including South Florida’s first proton therapy center. We are the only cancer center in the world to offer all of the latest radiation therapies in one place, which enables us to choose what treatment is right for you.